← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Fox Chase Cancer Center /Inc/
$0
Total funding
2
Grants
Funding over time
peak $0 · FY2005–06$1$1$1$0$0
'05
'06
Funding mix
By agency
NIH$0 · 2
By mechanism
N01$0 · 2
Investigators at Fox Chase Cancer Center /Inc/
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
A PHASE IIB CANCER PREVENTION TRIAL OF NSAIDS IN ORAL LEUKOPLAKIA-WS N-261025011$0
N01 · FY2004 · CN
PHASE I SINGLE AND MULTIPLE-DOSE SAFETY AND PHARMACOKINETIC AND DRUG -261025120$0
N01 · FY2006 · CN
PHASE I. IN VIVO AND IN VITRO PHARMACOLOGY OF A CHEMOPREVENTIVE AGENT -261025120$0
N01 · FY2004 · CN
PHASE I SINGLE AND MULTIPLE-DOSE SAFETY AND PHARMACOKINETIC AND DRUG -261025120$0
N01 · FY2005 · CN